At a glance
- Originator Nonindustrial source
- Class Antithrombotics
- Mechanism of Action Purinoceptor P2Y12 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 18 Apr 2002 No development reported - Preclinical for Thrombosis in USA (unspecified route)
- 18 Sep 2000 Preclinical development for Thrombosis in USA (Unknown route)